156 related articles for article (PubMed ID: 38406957)
41. Post transplant Kaposi's sarcoma among Nigerians: a report of two cases.
Abdu A; Adamu B; Sani MU; Mohammed AZ; Alhassan SU; Borodo MM
Afr J Med Med Sci; 2005 Dec; 34(4):395-8. PubMed ID: 16752672
[TBL] [Abstract][Full Text] [Related]
42. The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy.
Ondrus D; Pribylincová V; Breza J; Bujdák P; Miklosi M; Reznícek J; Zvara V
Int Urol Nephrol; 1999; 31(4):417-22. PubMed ID: 10668934
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review.
Zhang J; Ma L; Xie Z; Guo Y; Sun W; Zhang L; Lin J; Xiao J; Zhu Y; Tian Y
Med Oncol; 2014 Jul; 31(7):32. PubMed ID: 24908063
[TBL] [Abstract][Full Text] [Related]
44. Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening.
Asch WS; Bia MJ
Adv Chronic Kidney Dis; 2014 Jan; 21(1):106-13. PubMed ID: 24359993
[TBL] [Abstract][Full Text] [Related]
45. Post-transplant malignancy: reducing the risk in kidney transplant recipients.
Wu C; Shapiro R
Expert Opin Pharmacother; 2011 Aug; 12(11):1719-29. PubMed ID: 21480821
[TBL] [Abstract][Full Text] [Related]
46. Post renal-transplant malignancy surveillance.
Manickavasagar R; Thuraisingham R
Clin Med (Lond); 2020 Mar; 20(2):142-145. PubMed ID: 32188647
[TBL] [Abstract][Full Text] [Related]
47. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
Opelz G; Unterrainer C; Süsal C; Döhler B
Nephrol Dial Transplant; 2016 Aug; 31(8):1360-7. PubMed ID: 27190384
[TBL] [Abstract][Full Text] [Related]
48. Urothelial carcinoma of donor origin in a kidney transplant patient.
Michel Ortega RM; Wolff DJ; Schandl CA; Drabkin HA
J Immunother Cancer; 2016; 4():63. PubMed ID: 27777772
[TBL] [Abstract][Full Text] [Related]
49. The incidence of post-transplant malignancies in kidney transplant recipients treated with Rituximab.
Bachelet T; Visentin J; Davis P; Taton B; Guidicelli G; Kaminski H; Merville P; Couzi L
Clin Transplant; 2021 Feb; 35(2):e14171. PubMed ID: 33247459
[TBL] [Abstract][Full Text] [Related]
50. Cancers after renal transplantation.
Wong G; Chapman JR
Transplant Rev (Orlando); 2008 Apr; 22(2):141-9. PubMed ID: 18631867
[TBL] [Abstract][Full Text] [Related]
51. Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study.
Hellström VC; Enström Y; von Zur-Mühlen B; Hagberg H; Laurell A; Nyberg F; Bäckman L; Opelz G; Döhler B; Holmberg L; Tufveson G; Enblad G; Lorant T
Acta Oncol; 2016 Jun; 55(6):774-81. PubMed ID: 26824275
[TBL] [Abstract][Full Text] [Related]
52. Emerging Concepts in Managing Malignancy in Kidney Transplant Patients.
Schreiber B; Abdelrahim M; Abudayyeh A; Murakami N
Semin Nephrol; 2022 Jan; 42(1):63-75. PubMed ID: 35618396
[TBL] [Abstract][Full Text] [Related]
53. Malignant disease in renal transplant recipients--our experience.
Blagojević-Lazić R; Radivojević D; Andrejević V; Dzamić Z; Acimović M; Milutinović D; Djurasić L; Hadzi-Djokić J
Acta Chir Iugosl; 2012; 59(1):49-51. PubMed ID: 22924303
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
55. Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.
Frascà GM; Brigante F; Volpe A; Cosmai L; Gallieni M; Porta C
J Nephrol; 2019 Feb; 32(1):57-64. PubMed ID: 30328092
[TBL] [Abstract][Full Text] [Related]
56. Belatacept for kidney transplant recipients.
Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
[TBL] [Abstract][Full Text] [Related]
57. Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients.
Rahatli S; Altundag O; Ayvazoglu Soy E; Moray G; Haberal M
Exp Clin Transplant; 2020 Aug; 18(4):470-473. PubMed ID: 30119617
[TBL] [Abstract][Full Text] [Related]
58. Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma.
Meier RPH; Muller YD; Dietrich PY; Tille JC; Nikolaev S; Sartori A; Labidi-Galy I; Ernandez T; Kaur A; Hirsch HH; McKee TA; Toso C; Villard J; Berney T
Transplantation; 2021 Feb; 105(2):423-429. PubMed ID: 32091486
[TBL] [Abstract][Full Text] [Related]
59. Malignancies arising in allograft kidneys, with a first reported translocation RCC post-transplantation: A case series.
Saleeb R; Faragalla H; Yousef GM; Stewart R; Streutker CJ
Pathol Res Pract; 2015 Aug; 211(8):584-7. PubMed ID: 26008778
[TBL] [Abstract][Full Text] [Related]
60. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.
Wimmer CD; Rentsch M; Crispin A; Illner WD; Arbogast H; Graeb C; Jauch KW; Guba M
Kidney Int; 2007 Jun; 71(12):1271-8. PubMed ID: 17332737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
